Form 4: Strata Critical Medical Insider Sells Shares

Melissa M. Tomkiel, Co-CEO and General Counsel of Strata Critical Medical, Inc., reported a transaction involving the sale of 29,730 shares of Class A common stock.

Summary

• Melissa M. Tomkiel, a Director and Officer (Co-CEO and General Counsel) of Strata Critical Medical, Inc., reported a transaction on June 8, 2026.
• The transaction involved the disposition of 29,730 shares of Class A common stock.
• These shares were withheld by the Issuer to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following this transaction, Tomkiel beneficially owns 1,892,774 shares of Class A common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as the reported share disposition is a standard procedure for tax withholding related to RSU vesting and does not necessarily indicate a negative view of the company's prospects by the insider.

Negatives

• Insider selling, even if for tax withholding, can sometimes be perceived negatively by the market.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While this specific transaction relates to tax withholding for vested RSUs, any insider disposition of shares warrants attention from investors monitoring insider activity.

Stakeholder Impact

• Shareholders: The disposition of shares by an insider, even for tax purposes, may be monitored for potential market sentiment impact, though the reason for the sale mitigates direct negative interpretation.

Key Dates

Keywords

Strata Critical Medical, SRTA, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, Melissa M. Tomkiel, Director, Officer